Promino cancels placement, arranges $1M placement

Executive Summary

• Promino Nutritional Sciences Inc. cancels its previously announced non‑brokered private placement of secured convertible debentures.
• The company now proposes a new non‑brokered private placement of up to 50 million units (potentially increased by 25 million additional units) at C$0.02 per unit, targeting gross proceeds of up to C$1 million (or up to C$1.5 million if the increase is exercised).
• Net proceeds will be used to accelerate growth through inventory investments and for general corporate purposes; closing expected around Jan. 30 2026 pending regulatory approvals.

Key Details

• Cancellation: Prior non‑brokered private placement of secured convertible debentures announced on Dec. 9 and Dec. 12, 2025 is being cancelled.
• New Offering Size: Up to 50 million units; option to increase by an additional 25 million units, for total possible gross proceeds of C$1.0‑1.5 million.
• Pricing: Units priced at C$0.02 each.
• Unit Composition: Each unit consists of one common share plus one common share purchase warrant.
• Warrant Terms: Warrants exercisable to purchase one additional share at C$0.06 per share, valid for 12 months from issuance.
• Use of Proceeds: (a) Accelerate growth through inventory investments; (b) General corporate purposes.
• Closing Date: Expected on or about Jan. 30, 2026, subject to execution of subscription agreements and receipt of all required regulatory approvals, including CSE approval.
• Resale Restriction: All securities issued will be subject to a four‑month‑and‑one‑day statutory resale restriction under Canadian securities law.

Notable Quotes

(No executive quotes were provided in the release.)